{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:21:26Z","timestamp":1783621286908,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cll.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:33:48Z","timestamp":1774388028000},"page":"153-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Updates on Von Willebrand Disease Testing"],"prefix":"10.1016","volume":"46","author":[{"given":"Eric","family":"Salazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell A.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cll.2026.02.001_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.cll.2026.02.001_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.cll.2026.02.001_bib3","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.hoc.2021.07.005","article-title":"Acquired von Willebrand Syndrome","volume":"35","author":"Langer","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"10.1016\/j.cll.2026.02.001_bib5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J Thromb Haemostasis"},{"issue":"12","key":"10.1016\/j.cll.2026.02.001_bib6","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.cll.2026.02.001_bib7","author":"Rodeghiero"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0042-1749591","article-title":"Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program","volume":"48","author":"Salazar","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.cll.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0034-1383546","article-title":"Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions","volume":"40","author":"Favaloro","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.cll.2026.02.001_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.cll.2026.02.001_bib14","first-page":"362","article-title":"Ristocetin--a new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thrombosis Diath Haemorrh"},{"issue":"2","key":"10.1016\/j.cll.2026.02.001_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ajcp\/63.2.210","article-title":"Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation","volume":"63","author":"Olson","year":"1975","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2026.02.001_bib16","article-title":"Commentary on \"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD\": reflections based on recent contemporary test data","author":"Favaloro","year":"2021","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.cll.2026.02.001_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12807","article-title":"Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: limitations of relying on a single measure","volume":"6","author":"Christopherson","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0042-1754332","article-title":"Diagnostic Testing for von Willebrand Disease: trends and Insights from North American Laboratories over the Last Decade","volume":"48","author":"Ziemba","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib20","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1177\/1076029610379848","article-title":"Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease","volume":"17","author":"Trossa\u00ebrt","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pathol.2021.07.001","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays","volume":"54","author":"Favaloro","year":"2022","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib22","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","article-title":"Type 2M von Willebrand disease - more often misidentified than correctly identified","volume":"22","author":"Favaloro","year":"2016","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.cll.2026.02.001_bib23","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/jth.14319","article-title":"Clinically relevant differences between assays for von Willebrand factor activity","volume":"16","author":"Boender","year":"2018","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ajh.25393","article-title":"Automated assays for von Willebrand factor activity","volume":"94","author":"Higgins","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib25","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1111\/j.1365-2516.2011.02662.x","article-title":"Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity","volume":"18","author":"Lasne","year":"2012","journal-title":"Haemophilia"},{"issue":"10","key":"10.1016\/j.cll.2026.02.001_bib26","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2011.04460.x","article-title":"Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay","volume":"9","author":"Chen","year":"2011","journal-title":"J Thromb Haemostasis"},{"issue":"8","key":"10.1016\/j.cll.2026.02.001_bib27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib28","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the molecular and clinical biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","article-title":"Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin","volume":"36","author":"Graf","year":"2014","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.cll.2026.02.001_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12064","article-title":"A comparative evaluation of a new automated assay for von Willebrand factor activity","volume":"19","author":"Lawrie","year":"2013","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.cll.2026.02.001_bib31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jth.14145","article-title":"A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients","volume":"16","author":"Vangenechten","year":"2018","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102422","article-title":"Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assays","volume":"8","author":"Friedman","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cll.2026.02.001_bib33","article-title":"Chemiluminescent immunoassay technology: what does it change in autoantibody detection?","volume":"8","author":"Cinquanta","year":"2017","journal-title":"Auto Immun Highlights"},{"issue":"1","key":"10.1016\/j.cll.2026.02.001_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","article-title":"A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen","volume":"20","author":"Stufano","year":"2014","journal-title":"Haemophilia"},{"issue":"16","key":"10.1016\/j.cll.2026.02.001_bib36","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2008-10-184317","article-title":"Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor","volume":"114","author":"Riddell","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/hae.13957","article-title":"Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies","volume":"26","author":"Favaloro","year":"2020","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.cll.2026.02.001_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0029-1214149","article-title":"Toward a new paradigm for the identification and functional characterization of von Willebrand disease","volume":"35","author":"Favaloro","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1538-7836.2007.02437.x","article-title":"von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2","volume":"5","author":"Veyradier","year":"2007","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.cll.2026.02.001_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.thromres.2019.07.010","article-title":"How we make an accurate diagnosis of von Willebrand disease","volume":"196","author":"Baronciani","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1055\/s-0043-1777795","article-title":"From field study to clinical practice, a personal historical experience using the PFA-100 analyzer for platelet function testing","volume":"50","author":"Gosselin","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ajh.24620","article-title":"Clinical utility of closure times using the platelet function analyzer-100\/200","volume":"92","author":"Favaloro","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cll.2026.02.001_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2020.01.029","article-title":"Utility of the platelet function analyser (PFA-100\/200) for exclusion or detection of von Willebrand disease: a study 22 years in the making","volume":"188","author":"Favaloro","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1538-7836.2008.02909.x","article-title":"Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study","volume":"6","author":"Tiede","year":"2008","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1505643","article-title":"Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement","volume":"375","author":"Van Belle","year":"2016","journal-title":"NEJM"},{"issue":"16","key":"10.1016\/j.cll.2026.02.001_bib46","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4495","article-title":"Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel Electrophoresis","volume":"12","author":"Gritsch","year":"2022","journal-title":"Bio Protoc"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.thromres.2010.09.015","article-title":"Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging","volume":"126","author":"Pruthi","year":"2010","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib48","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPH5JK4ONENPAE","article-title":"Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience","volume":"135","author":"Chandler","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.cll.2026.02.001_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.cll.2026.02.001_bib50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ijlh.13107","article-title":"Semi-automated von Willebrand factor multimer assay for von Willebrand disease: further validation, benefits and limitations","volume":"41","author":"Oliver","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"15","key":"10.1016\/j.cll.2026.02.001_bib51","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2015-04-512731","article-title":"von Willebrand factor propeptide: biology and clinical utility","volume":"126","author":"Haberichter","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2026.02.001_bib52","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/labmed\/lmab104","article-title":"Recurrent gastrointestinal bleeding in a middle-aged man","volume":"53","author":"Gowani","year":"2022","journal-title":"Lab Med"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/hae.14970","article-title":"Diagnosis and treatment of von Willebrand disease in 2024 and beyond","volume":"30","author":"James","year":"2024","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib54","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemostasis"},{"issue":"5","key":"10.1016\/j.cll.2026.02.001_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MOH.0000000000000524","article-title":"The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease","volume":"26","author":"Flood","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.cll.2026.02.001_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:03:25Z","timestamp":1783620205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271226000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272271226000016"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2026.02.001","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on Von Willebrand Disease Testing","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}